Uttar Pradesh-based pharma major Jubilant Organosys Ltd (JOL) has secured new contracts worth $92 million (Rs.3.7 billion). The contracts have been signed under Customs Research and Manufacturing Services (CRAMS). Besides marketing its products in the regulated markets of the US, Europe and Japan, the company has managed to make forays into China, said a statement of JOL. The momentum in CRAMS related outsourcing is accelerating. The signing of agreements is expected to translate into considerable improved performance in the key pharmaceutical and life sciences segment during the calendar year 2008.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment